Fifth Third Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Fifth Third Wealth Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$237K	Sell	4,948 -719	-13%	-$30.9K	0.01%	839
2026 Q1	$208K	Sell	5,667 -383	-6%	-$18.1K	0.01%	781
2025 Q4	$308K	Buy	6,050 +19	+0.3%	+$972	0.01%	572
2025 Q3	$335K	Buy	6,031 +603	+11%	+$35.3K	0.01%	513
2025 Q2	$375K	Buy	5,428 +1,249	+30%	+$85K	0.02%	453
2025 Q1	$290K	Buy	4,179 +1,064	+34%	+$87.9K	0.02%	504
2024 Q4	$268K	Sell	3,115 -544	-15%	-$58.8K	0.01%	540
2024 Q3	$436K	Buy	3,659 +1,873	+105%	+$250K	0.03%	347
2024 Q2	$255K	Buy	+1,786	New	+$237K	0.02%	479

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fifth Third Wealth Advisors's NVO Position: Q2 2026 in Review

Fifth Third Wealth Advisors reduced its Novo Nordisk (NVO) stake by 13% in Q2 2026, selling an estimated $30.9K and leaving 4,948 shares worth $237K. The position accounts for 0.01% of the portfolio, ranked #839.

Fifth Third Wealth Advisors first reported a position in NVO in Q2 2024 and has held it in 9 quarters since. The position peaked at $436K in Q3 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Fifth Third Wealth Advisors held 4,948 shares of Novo Nordisk worth $237K as of Q2 2026.
Fifth Third Wealth Advisors sold 719 Novo Nordisk shares in Q2 2026, an estimated $30.9K.
Novo Nordisk made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #839 holding.
Fifth Third Wealth Advisors first reported a position in Novo Nordisk in Q2 2024 and has held it in 9 quarters since.
Fifth Third Wealth Advisors's Novo Nordisk position peaked at $436K in Q3 2024.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.